跳至主要内容
临床试验/NCT01542138
NCT01542138已完成4 期

A Double Blind, Randomized Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

Universidad Autonoma de San Luis Potosí1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Pigmentation

研究概览

简要总结

Axillary hyperpigmentation is a frequent consultation in dark skin populations although its exact prevalency is unknown. Currently, there are not studies about physiopathology and treatment for this entity. The objective is to evaluate the depigmenting effect of topical 4% niacinamide versus 0.05% desonide in axillary hyperpigmentation.

At least 30 axillas with hyperpigmentation in individuals of phototype III-V, aged 18-50 years are going to be randomly assigned to receive niacinamide, desonide or placebo daily. No hygienic habits will not be modified. Volunteers will be evaluated at baseline and for 9 weeks, by means of histological, histochemical and immunohistochemistry analysis, as well as Transepidermal Water Loss (TEWL), colorimetry, clinically and by photography control.

详细描述

Axillary hyperpigmentation is frequent in dark skin population, is possible a type of postinflammatory hyperpigmentation present in phototypes IV to VI. Previous reports have described increased intensity of Masson-Fontana, anti-tyrosinase and/or anti-TRP1 staining, indicative of melanocyte stimulation and increased melanin production, but the exact mechanism is unknown. The hair plucking, the rubbing of clothes on skin and physical stimulation from washing and drying the underarm are factors implicated. The objective of our study is evaluate the depigmenting effect of topical niacinamide versus desonide in axillary hyperpigmentation through the histochemistry and immunohistochemistry staining.

The study population will include at least 30 axillas with hyperpigmentation in a population with phototype III-V and aged 18-50 years old. Informed consent will be obtained from the patients, under approval by the local ethical committee (Institutional Review Board). The patients are going to be randomly assigned to receive 4% niacinamide, 0.05% desonide or placebo daily once at night. None hygienic habit is going to be modified. Volunteers will be evaluated at baseline and 9 weeks later, with histochemical and immunohistochemical analysis (biopsies), colorimetric value axis L*, a*, b* (Chromameter CR-300, Minolta, Osaka, Japan), Transepidermal Water Loss (TEWL) by means of an evaporimeter (Dermalab, Cortex Technology, Denmark), clinical assessment and photography control.

Statistical analysis was performed using t student, the level of significance was set at 5%. And clinical evaluation will be analysed by means of chi square test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women over 18 years old
  • Clinical diagnosis of axillar hyperpigmentation

排除标准

  • Pregnancy or lactation
  • Endocrinological diseases
  • Mental diseases
  • Treatment for axillar hyperpigmentation in the last 2 months

研究组 & 干预措施

Niacinamide

Active Comparator

4% niacinamide cream that will be randomly applied on axillar hyperpigmentation once-a-day for 9 weeks.

干预措施: Niacinamide (Drug)

Desonide

Active Comparator

Once-a-day application of 0.05% desonide cream on axillar hyperpigmentation

干预措施: Desonide (Drug)

Placebo

Placebo Comparator

Humectant placebo cream

干预措施: Placebo (Drug)

结局指标

主要结局

Pigmentation

时间窗: 9 weeks

Quantification of melanin content in histologic sections by Fontana-Masson stain

次要结局

  • Inflammation(9 weeks)
  • Trauma(9 weeks)
  • Change in transepidermal water loss in hyperpigmented lesion(9 weeks)
  • Investigator's Depigmentation Improvement(9 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan Pablo Castanedo Cazares

Dermatology research director

Universidad Autonoma de San Luis Potosí

研究点 (1)

Loading locations...

相似试验